07:00 , Mar 30, 2009 |  BioCentury  |  Emerging Company Profile

Carigent: The tail is the tale

The dual challenge of liposomal-based delivery of biologics has been to increase time in circulation and reach target organs before the delivery device degrades or prematurely releases its payload. Carigent Therapeutics Inc. believes its ability...
07:00 , Mar 30, 2009 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Carigent Therapeutics Inc. New Haven, Conn. Technology: Polymer-based drug delivery Disease focus: Cancer, cardiovascular, autoimmune Clinical status: Preclinical Founded: 2007 by W. Mark Saltzman, Tarek Fahmy and Seth Feuerstein University collaborators: Yale University and Cornell...
08:00 , Dec 3, 2007 |  BC Week In Review  |  Company News

HistoRx board of directors update

HistoRx Inc. , New Haven, Conn.   Business: Diagnostic   Appointed: Gregory Gardiner, a director, as chairman; and Seth Feuerstein, president of Carigent Therapeutics Inc.  ...